The Fate of Resectable Pancreatic Adenocarcinoma After Neoadjuvant Chemotherapy. Irfan A, Rose JB, Wang TN, Vickers SM, et al. Pancreas 2022;51:100-105.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Irfan A, Rose JB, Wang TN, Vickers SM, et al. The Fate of Resectable Pancreatic Adenocarcinoma After Neoadjuvant Chemotherapy. Pancreas 2022;51:100-105.
PMID: 35195602